Canadian researchers discover new way to prevent infections in dialysis patients

Jan 26, 2011

Researchers have discovered that a drug used to treat dialysis catheter malfunction in kidney dialysis patients may now also help prevent both malfunction as well as infections.

Dr. Brenda Hemmelgarn from the University of Calgary Faculty of Medicine and her colleague Dr. Nairne Scott-Douglas, both members of the Libin Cardiovascular Institute of Alberta, undertook a randomized trial at 11 sites across Canada. 115 were administered the usual catheter locking solution of heparin after every dialysis session, while 110 patients received rt-PA once a week. Researchers found that those receiving only heparin were twice as likely to suffer a catheter malfunction and were at an almost three-fold increased risk of blood stream infection.

"We now have evidence that we can prevent these complications using rt-PA, with a goal to ultimately improve outcomes for patients with ," says Hemmelgarn.

Didja Nawolsky knows the importance of avoiding infection. In 2003 her kidney failed and she has been on dialysis ever since. She has had 15 permanent and temporary and her constant concern is avoiding infections.

"An infection can easily get into my blood stream and cause serious problems. The line also has to be removed and replaced when there is an infection, which is a rather unpleasant experience I prefer to avoid. This research will benefit myself and others using catheters because it reduces infections, which is hugely important," she says.

Patients with kidney failure undergo hemodialysis, a treatment used to clean their blood. A catheter placed into the blood system is often required to undertake the hemodialysis procedure. However, there are often complications with the dialysis catheter known as 'catheter malfunction' that involve forming at the catheter tip, as well as infections in the . is used as a locking solution in the catheter after dialysis to help prevent malfunction, and keep the dialysis catheter working for a longer period of time.

"Given the considerable cost of blood infections and catheter malfunction physicians should consider using r-TPA prohylactically to prevent these complications in higher risk patients," says Scott-Douglas.

Explore further: Experimental Ebola drug heals all monkeys in study (Update)

More information: These research findings are published in the January 26th edition of the New England Journal of Medicine.

add to favorites email to friend print save as pdf

Related Stories

Kidney disease treatment may harm patients

Oct 12, 2007

Central venous catheters are commonly used to provide permanent hemodialysis for patients with serious kidney disease. One technique, inserting a catheter through large vessels, has been commonly used worldwide in recent ...

Overnight hemodialysis dramatically improves survival

Nov 08, 2008

For hemodialysis patients, undergoing dialysis for eight hours overnight, three times weekly, reduces the risk of death by nearly 80 percent, compared to conventional, four-hour dialysis, according to research being presented ...

Recommended for you

Ebola in mind, US colleges screen some students

7 hours ago

University students from West Africa may be subject to extra health checks when they arrive to study in the United States as administrators try to insulate their campuses from the worst Ebola outbreak in ...

WHO: More Ebola cases in past week than any other

9 hours ago

The past week has seen the highest increase of Ebola cases since the outbreak in West Africa began, the World Health Organization said Friday, offering more evidence that the crisis is worsening.

User comments : 0